About Limbix
Limbix is a Healthcare company based in Palo Alto (United States) founded in 2016, and was acquired by BigHealth in July 2023. VR-based exposure therapy for anxiety and phobias is provided. Limbix has raised $27 million across 6 funding rounds from investors including NIH, Korea Investment Holdings and HHS. The company has 55 employees. Limbix offers products and services including Sleepio, Daylight, and Spark Direct. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Patient Engagement. Its competitors include Mindoula, Woebot Health and PursueCare; 3 of its 3 listed competitors have raised funding.
Company details
Provider of VR-based stress management solutions. It provides a platform that enables therapists to administer virtual reality exposure therapy solutions to help patients overcome anxiety, phobia, obsessive-compulsive disorder, and substance abuse. Its platform allows therapists to manage their patient exposure levels within VR scenes providing personalized treatment. Therapists can log in to the platform to add patients, create assignments, and monitor progress. Patients can then use a mobile app to complete action plans, enter thought records and assessments, listen to guided meditations and provide therapist feedback.
- Headquarters Palo Alto, United States
- Employees 55
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website limbix.com
- Social LinkedIn X Facebook
- Acquired by BigHealth (Jul 2023)
- Legal Name Limbix
Products & Services of Limbix
Limbix offers a comprehensive portfolio of products and services, including Sleepio, Daylight, and Spark Direct.
Program to improve sleep quality using CBT techniques.
Program for managing worry and anxiety effectively.
Program to enhance mood and well-being through behavioral methods.
Funding Insights of Limbix
Limbix has successfully raised a total of $27M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27M
- Total Rounds 6
- Last Round Series A — $15M
- First Round $3M
(Mar 2019)
- Investors Count 17
All 6 funding rounds of Limbix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $15M | Series A | – | GSR Ventures | |
| Mar 2021 | Grant | – | – | ||
| Feb 2021 | $2.17M | Grant | – | – | |
| May 2020 | $9M | Series A | – | GSR Ventures | |
| Sep 2019 | $225,000 | Grant | – | – | |
| Mar 2019 | $3M | Seed | – | – |
18 investors in total: 18 institutional.
Investors in Limbix
Limbix has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Korea Investment Holdings and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech startups are invested in by GSR Ventures. | gsrventuresglobal.com | Beijing, China | ||
Venture capital fund focused on multiple sectors | stormventures.com | Menlo Park, United States | ||
Venture capital firm focused on software, fintech, marketplaces, and consumer internet | dncapital.com | London, United Kingdom | ||
| eninvestment.co.kr | ||||
Venture capital investing with a focus on diversity and inclusion in the ecosystem. | gaingels.com | |||
Early-stage venture firm focused on healthcare technology investments. | pac.vc | Menlo Park, United States | ||
Investment holding firm established in Seoul in 2003. | 2003 | koreainvestment.com | Seoul, South Korea | |
Venture capital firm investing in tech sectors | operatorpartners.com | New York, United States | ||
Investments in early-stage tech firms and consumer brands are made. | manaventures.vc | San Francisco, United States | ||
Venture capital firm investing in multiple sectors | mvp-vc.com | Menlo Park, United States |
Investor details for Limbix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Limbix
44 people are tracked at Limbix (14 in leadership, 4 in board & advisors, 26 in team); the tracked headcount is 55.
| Name | Role | Group |
|---|---|---|
Craig Schmidt | Director Of Engineering | Leadership |
Jenna Carl | VP, Clinical Development & Medical Affairs | Leadership |
Colin Espie | Co-Founder & Chief Scientist | Leadership |
John Walsh | Chief Product & Technology Officer | Leadership |
Brendon Kelly | Sales Director | Leadership |
Jason O'Connor | Sales Director | Leadership |
Yael Berman | CEO | Leadership |
Dani Bradley | Vice President, Clinical Affairs | Leadership |
Jared Smith | Sales Director, Health Plan Sales | Leadership |
William Walters | Director, National Accounts | Leadership |
Tali Ball | Head Of Clinical Product Development | Leadership |
Reuben Lawson | Vice President, Regulatory Affairs And Quality Systems | Leadership |
Dane Wetschler | Director, Patient Products And Growth | Leadership |
Andrew Rocklage | Director, Legal And Business Affairs | Leadership |
Bruce Keogh | Advisor | Board & advisors |
Shantanu Nundy | Advisor | Board & advisors |
Nora Dennis | Advisor | Board & advisors |
Andy Krystal | Advisor | Board & advisors |
Charlie Davis | Data / Product Analyst | Team |
Joe S. | Senior Software Engineer | Team |
24 more people are available in the full profile.
Complete people profiles for Limbix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Limbix
4 dated milestones of Limbix across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Limbix is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Series A, of $15.0M.
- Exit Acquired by BigHealth.
Competitors of Limbix
Limbix has 3 listed competitors in our database, 3 of them funded. They include Mindoula, Woebot Health and PursueCare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mindoula.com | 2013 | Bethesda, United States | $31.05M | 254 | Virtual care management for behavioral health is provided by Mindoula. | |
| woebothealth.com | 2017 | San Francisco, United States | $99.5M | AI-powered chat-based mental wellness tools are developed. | ||
| pursuecare.com | 2018 | Middletown, United States | $27M | 84 | Addiction treatment is delivered via mobile app teleconsultations. |
Detailed competitors of Limbix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Limbix (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Limbix
Complete news archive for Limbix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Limbix
Limbix was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Limbix is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Limbix is a funded company, having raised a total of $27M across 6 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Mar 2019.
Limbix has 55 employees.
Provider of VR-based stress management solutions. It provides a platform that enables therapists to administer virtual reality exposure therapy solutions to help patients overcome anxiety, phobia, obsessive-compulsive disorder, and substance abuse. Its platform allows therapists to manage their patient exposure levels within VR scenes providing personalized treatment. Therapists can log in to the platform to add patients, create assignments, and monitor progress. Patients can then use a mobile app to complete action plans, enter thought records and assessments, listen to guided meditations and provide therapist feedback.
Limbix's top competitors include PursueCare, Woebot Health and Mindoula.
Limbix offers Sleepio, Daylight, and Spark Direct.
Limbix has 18 investors. Key investors include NIH, Korea Investment Holdings, HHS, BigHealth, and NextGen Venture Partners.
Limbix operates through Limbix.
Yes. Limbix was acquired by BigHealth in July 2023.